Introduction
Dengue virus infection presents as two clinical syndromes: dengue fever (DF)' and dengue hemorrhagic fever (DHF) (1) . 1 . Abbreviations used in thispaper: CTL, cytotoxic T lymphocyte; DF, dengue fever; DHF, dengue hemorrhagic fever; DSS, dengue shock syndrome; sCD4, sCD8, or sIL-2R, soluble CD4, CD8, or IL-2 receptor; WHO, World Health Organization.
DF is a self-limited febrile disease and is the most common type of dengue illness. Some patients with dengue virus infection leak plasma into the interstitial space resulting in hypovolemia and sometimes circulatory collapse. This severe syndrome, which is always accompanied by thrombocytopenia and sometimes by frank hemorrhage, is termed DHF (1) . The World Health Organization (WHO) categorized DHF cases into four grades, from less severe (grade 1) to sever (grade 4) (2) . Grades 3 and 4, in which plasma leakage is so profound that shock occurs, are also referred to as dengue shock syndrome (DSS) (2) . Epidemiological studies in Southeast Asia indicate that DHF is more commonly observed during secondary infections with a different serotype of virus from that which caused the primary infection (1, 3, 4) . A much higher incidence of DHF during secondary infections was also observed in a recent dengue epidemic in Cuba (5) . DHF occurs rarely during primary infections, but it has been observed in infants from 6 to 12 mo ofage born to dengue antibody-positive mothers (6) . It is known that antibody to dengue viruses at subneutralizing concentrations augments dengue virus infection of Fcy receptor (FcyR)-positive cells such as monocytes in vitro (7) , and it has been reported that passively transferred antibody enhances dengue virus infection in monkeys (8) . Based on these epidemiological and laboratory observations, it has been hypothesized that antibody to dengue virus increases the number of dengue virusinfected monocytes and lysis of these virus-infected cells may lead to DHF (1, 9) .
We have studied T lymphocyte responses to dengue viruses to determine their role in the pathogenesis ofDHF and in recovery from dengue virus infections. Dengue virus-specific, serotype-cross-reactive CD4' T lymphocytes produce interferon-y (IFN'y) after stimulation with dengue virus antigen (10) . IFN-y, which increases the number of FcyR, augments dengue virus infection of FcyR-positive cells in the presence of antibody to dengue virus (1 1). Furthermore, dengue virus-specific CD41 CD8-T lymphocytes and CD4-CD8' T lymphocytes lyse dengue virus-infected target cells in a human histocompatibility leukocyte antigen (HLA) class II-and HLA class I-restricted fashion, respectively (12, 13) . Based on these in vitro results, we have hypothesized that dengue virus-specific, serotype-cross-reactive T lymphocytes, which are activated during secondary dengue virus infection, may contribute to the pathogenesis of DHF by producing IFNy and by lysing dengue virus-infected monocytes (14) . It has also been reported that monocytes are among the most permissive cells for dengue virus replication (15) (16) (17) and that lymphokines produced by T lymphocytes activate monocytes (18 
Methods
Patients and normal control donors. Sera from three groups ofchildren were analyzed in this study. We examined serial serum specimens from 69 children (59 with DHF and 10 with DF), ages 4-14 yr, who were hospitalized with severe dengue virus infections during 1987 and 1988 in the hemorrhagic fever unit of the Bangkok Children's Hospital. These represent an unselected group of sequential patients whose sera were submitted for evaluation of suspected dengue infection. Specimens were collected by study nurses for diagnostic studies within 24 h of admission to the hospital and daily until discharge; a convalescent specimen was also collected from each child 7-15 d after hospital admission. A portion ofeach specimen was kept at -70°C and was available for analysis.
To study children with less symptomatic dengue infection, we also examined prospectively collected 14-d paired sera from 57 children, ages 6-14 yr, who were absent from school for > 2 d with a febrile illness during the period June to September 1989 . These children were participating in an approved prospective study ofthe incidence ofviral hepatitis in rural Thailand. Sera from this group of children were divided into specimens from children with documented dengue infections (n = 31) and from children with uncharacterized, non-flavivirus infections (n = 26). Acute sera were collected within 3 d of a child's confinement at home with fever; specimens were frozen at -70°C until analyzed. Convalescent sera were also collected and they were stored at -20°C. To study afebrile children (controls), we examined aliquots of single sera from a random sample of healthy Thai children (n = 97), ages 6-13 yr, obtained from an earlier approved cross-sectional study ofhepatitis antibody prevalence. These sera were stored at -70°C from the time of collection until assay. Levels of cytokines were examined after the first thaw, and levels of soluble cell surface proteins were examined after the second thaw, because soluble cell surface proteins are less susceptible to freezing and thawing than cytokines. Because the volumes of the sera obtained from patients were limited, all the sera could not be examined for every cytokine or soluble cell surface protein.
Diagnoses of DHF were assigned to children with dengue infection when the level of thrombocytopenia and signs of hemorrhage and plasma leakage met established criteria (2). Hospitalized patients were followed with frequent determinations of blood pressure and pulse. Measurements of hematocrit in blood obtained by finger prick were recorded at 1-8-h intervals, according to vital signs. Physical findings of plasma leakage (pleural effusion, ascites, cyanosis, cold extremities) were recorded in the clinical record. Whenever feasible, chest radiographs including decubitus views were performed to document the presence of pleural fluid. Hemorrhagic manifestations (positive tourniquet test for capillary fragility, skin hemorrhages, epistaxis, gingival, gastrointestinal, or urinary tract hemorrhage) were also recorded. Upon hospital discharge, the WHO grade of dengue illness was determined by a review ofthe clinical record. Without knowledge ofcytokine or soluble lymphocyte marker levels, the authors (Drs. Nisalak, Innis, and Nimmannitya) reviewed every record including radiographs and confirmed the assignment of WHO grade. All mildly symptomatic serologically confirmed dengue infections in outpatients were classified as dengue fever. Hospitalized cases ofdengue infection that did not meet diagnostic criteria for DHF were classified as DF (n = 10) along with mildly symptomatic outpatients.
Dengue virus and Japanese encephalitis virus infections were confirmed by detection of antiviral IgM or rising titers of antiviral hemagglutination-inhibiting antibodies and by virus isolation from plasma, according to previously published methods (24) . No patient in the Children's Hospital group had a serological diagnosis ofJapanese encephalitis. Two patients in the outpatient group had a serological diagnosis of Japanese encephalitis virus infection. These two patients were excluded from this study. Cases of dengue infection were categorized as secondary (dengue infection in a child previously infected with a heterologous flavivirus) or primary (no prior flavivirus infection) according to the presence or absence of an anamnestic anti-flavivirus antibody response (24). Table I shows age and sex distribution, and serological data of the donors.
Assays for sIL-2R, sCD4, and sCD8. The levels of sIL-2R, sCD4, and sCD8 were measured using commercial enzyme-linked immunosorbent assays (ELISA) (cell-free interleukin-2 receptor test kit, cellfree CD4 test kit, and cell-free T8 test kit, respectively) purchased from T Cell Sciences, Inc., Cambridge, MA. The results are expressed in units per milliliter based on the standard provided by the manufacturer. DHF. The arithmetic mean titers (shown as ) of sIL-2R were 665 U/ml (n = 28) in the sera of healthy Thai children; 1,475 U/ml (n = 16) on days 1-2, 1,325 U/ml (n = 9) on days 3-4, and 1,050 U/ml (n = 32) on days 10-20 in the sera of patients with DF; 2,150 U/ml (n = 21) on days 3-4, 2,019 U/ml (n = 33) on days 5-6, 1,681 U/ml (n = 16) on days 7-8, and 1,225 U/ml (n = 27) on days 10-20 in the sera of patients with DHF. In DHF and DF, (o) primary, hospitalized; (-) secondary, hospitalized; (o) primary, not hospitalized; (*) secondary, not hospitalized. Levels of sIL-2R were compared with the levels in the healthy children by Student's t test. ***P <0.001.
AssaysforIL-2. The levels ofIL-2 were measured using commercial ELISA (Intertest-2) purchased from Genzyme, Boston, MA. The levels of IL-2 are expressed in units per milliliter.
Assayfor IFNy. Levels ofIFNy were measured using a commercial radioimmunoassay (RIA) (Centocor gamma interferon radioimmuno- (25) . When the titers of lymphokines and soluble cell surface proteins differed > 10-fold in a group of sera, the titers were log-transformed. Therefore, titers of IL-2 and IFNy were log-transformed for statistical analysis. Undetectable levels of IL-2 (< 4 U/ml) and IFNy (< 0.07 U/ml) were considered 1 and 0.05 U/ml for log-transformation, respectively. When data of one subject were available on each adjacent day for analyses shown in Figs. [1] [2] [3] [4] [5] and Table II (e.g., days 3 and 4 after onset of fever), the arithmetic mean titers were used for sIL-2, sCD4, and sCD8; and the geometric mean titers were used for IL-2 and IFNy. Differences yielding P values of < 0.05 were regarded as significant. The sera from patients with DHF or DF were examined for the levels of sIL-2R, sCD4, and sCD8, and the levels were compared with those in the sera of healthy Thai children.
The levels of sIL-2R were significantly higher in the sera of patients with DHF and in the sera of patients with DF than in the sera ofhealthy Thai children during the examined period (P < 0.001 for DHF, P < 0.001 for DF) (Fig. 1) .
The levels of sCD4 were higher in the sera of patients with DHF on days 3-8 after onset of fever (P < 0.001) than in the healthy children. The levels ofsCD4 in the sera ofpatients with DF were higher than the levels in healthy children on days 1-2 after onset of fever (P < 0.05), but not on days 3-4 (Fig. 2) .
The levels of sCD8 were higher in the sera of patients with DHF on days 3-20 after onset of fever than in the sera of healthy children (P < 0.001). The levels of sCD8 in the sera of - Figure 2 . Levels of soluble CD4 (sCD4) in the acute sera of patients with DF or DHF. The arithmetic mean titers (shown as ) of sCD4 were 20.4 U/ ml (n = 40) in the sera ofhealthy Thai children; 24.9 (n = 15) on days 1-2, 18.7 U/ml (n = 9) on days 3-4, and 22.0 (n = I 1) on days 10-20 in the sera of patients with DF; 37.6 U/ml (n = 17) on days 3-4, 41.4 U/ml (n = 19) on days 5-6, 36.0 U/ml (n = 6) on days *i:--7-8, and 26.1 U/ml (n = 7) on days [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] Fig. 3) . These results suggest that CD4' T lymphocytes are activated in vivo during DHF and DF, and that activation of CD8' lymphocytes is evident in DHF, but not in DF.
Levels ofIL-2 and IFN-y in the sera ofpatients with DHFor DF. The sera from patients with DHF or DF were examined for IL-2 or IFN. IL-2 levels > 10 U/ml were detected in 63% (26/ 41) of patients with DHF during days 3-8 after onset of fever, and in 69% (18/26) of patients with DF during days 1-4, whereas only 2 of 28 sera of healthy children contained IL-2 > 10 U/ml (P < 0.001 for DHF, P < 0.001 for DF by X2square test) (Fig. 4) . The titers of IL-2 were significantly higher in the sera of patients with DHF (P < 0.001 on days 3-8, 10-20) and in the sera of patients with DF (P < 0.001 on days 1-2 and 10-20, and P < 0.01 on days 3-4) than in the sera of healthy Thai children (Fig. 4) . IFN-y was detected in 97% (34/35) of the patients with DHF, and in 91% (31/34) of patients with DF, while it was Figure 3 . Levels of sCD8 in the acute sera of patients with (DF) or DHF. The arithmetic mean titers (shown as ) of sCD8 were 416 U/ml (n = 31) in the sera of healthy Thai children; 359 U/ml (n = 16) on days 1-2, 344 U/ml (n = 9) on days 3-4, 334 U/ml (n = 30) on days 10-20 in the sera of patients with DF; 1,188 U/ml (n = 19) on days 3-4, 1,639 U/ml (n = 35) on days 5-6, 1,410 U/ml (n = 14) on days 7-8 and 1,112 U/ml (n = 10) on days 10-20 in the sera of patients with DHF. In DHF and DF, (o) primary, hospitalized; (-) secondary, hospitalized; (0) primary, not hospitalized; (,) secondary, not hospitalized. Levels of sCD8 were compared with the levels in healthy Thai children by Student's t test. ***P <0.001. detected in 13% (4/30) of the sera of healthy children (P < 0.001 for DHF, P < 0.001 for DF by x2 test) (Fig. 5) . The titers of IFNy in the sera of patients with DHF on days 3-8 (P < 0.001 on days 3-6 and P < 0.02 on days 7-8) and in the sera of patients with DF on days 1-4 (P < 0.001) were significantly higher than those in the sera of healthy children (Fig. 5) .
These results are consistent with those in Figs. 1-3 , and indicate that T lymphocytes are activated in vivo during DHF and DF.
Comparison ofthe levels ofsoluble cell surface proteins and lymphokines between DHF and DF. A comparison of sIL-2R, sCD4, sCD8, IL-2, and IFNy among patients with DHF or DF were made for sera collected on illness days 3-4, because specimens were obtained from patients with DHF during days 3-8 after onset of fever and from patients with DF during days 1-4. The sera of patients with DHF contained higher levels of sIL-2R (P < 0.05), sCD4 (P < 0.001), and sCD8 (P < 0.001) than the sera of patients with DF, although the levels of IL-2 and ) of IL-2 were 2.1 U/ml (n = 28) in the sera of healthy Thai children; 23.6 U/ml (n = 16) on days 1-2, 11.5 U/ml (n = 10) on days 3-4, 60.3 U/ml (n = 31) on days 10-20 in the sera of patients 4P with DF; 15.2 U/ml (n = 27) on days 3-4, 10.2 U/ml (n = 36) on 3 .
days 5-6, 7.9 U/ml (n = 15) on days ;r. (Fig. 6 ). The titers of IL-2 and IFNy were highest one day before defervescence (Fig. 7) . These results suggest that activation ofT lymphocytes reaches the peak as plasma leakage begins but before circulatory collapse becomes manifest.
Comparison of the levels of each serum factor among the WHO grades 1, 2, and 3 of DHF. The levels of soluble cell surface proteins and lymphokines were compared among grades 1, 2, and 3 of DHF from day -1 to day 3. Statistically Healthy Children Figure 5 . Levels of IFNy in the acute sera of patients with DHF and with DF. The geometric mean titers (shown as ) of IFNy were 0.064 U/ml (n = 30) in the sera of healthy Thai children, 0.604 U/ml (n = 21) on days 1-2, 0.945 U/ml (n = 18) on days 3-4, and 0.106 U/ml (n = 36) in the sera of patients with DF, and 0.904 U/ml (n = 28) on days 3-4, 0.231 U/ml (n = 34) on days 5-6, 0.125 U/ml (n = 18) on days 7-8, and 0.029 U/ml (n = 32) on days [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] 8 ) and in the levels of IL-2 between grade 2 and grade 3 1 d before defervescence (Fig. 9) . As a whole, the levels of sIL-2R, sCD4, sCD8, IL-2, and IFN-y were not different among grades 1, 2, and 3 of DHF. These results suggest that the degree of T cell activation is similar among grades 1, 2, and 3 of DHF, and that our grouping all grades of DHF for analysis was appropriate.
Correlation between the levels ofsIL-2R and those ofsCD4 in patients with DHF. We examined whether there were correlations between the levels of sIL-2R, sCD4, sCD8, IL-2, and IFNey in the acute sera of patients with DHF. The levels of sIL-2R positively correlated with those of sCD4 (P = 0.025) (Fig. 10 ). There were no other correlations among the levels of lymphokines and soluble cell surface proteins.
Discussion
We examined levels oflymphokines (IL-2 and IFNy) and soluble cell surface proteins (sIL-2, sCD4, and sCD8) released from activated T lymphocytes in unselected Thai children hospitalized with DHF. To determine whether differential cytokines or cellular immune responses were associated with hemorrhage and plasma leakage that are the pathognomonic feature of DHF, we also examined these same serum factors in patients who were infected with dengue virus but who did not have plasma leakage (dengue fever). Children with DF were drawn from the same consecutive hospital case series as those with DHF, or they were drawn from a consecutive series ofDF cases 100-10 - identified prospectively during a longitudinal study of illnesses leading to school absence in rural Thailand. To determine which findings in the entire set of patients with dengue virus infection were indicative of a host response to viral infection, we examined sera collected from healthy Thai children from the same cohort which yielded the dengue fever cases. (18) (19) (20) and IFNy (18, 20) , and release sIL-2R (21) . Activated CD8' T lymphocyte release sCD8 (22, 23) , while activated CD4' T lymphocytes release sCD4 (Susan Kline, personal communication). We previously reported that dengue virus-specific CD4' CD8-memory T cells are induced by dengue virus infections (10) . They produce IFNy (10, 12) and IL-2 (unpublished data) after stimulation with dengue virus antigens in vitro. We have also detected CD8' CD4-cytotoxic T lymphocytes (CTL) using lymphocytes of dengue virus-immune donors (13) . The Among patients with DF, the acute sera contained higher levels of sIL-2R, sCD4, IL-2, and IFNy than the sera ofhealthy children. SCD8 levels were not elevated in most cases; however, high levels of sCD8 were detected in the small number of hospitalized patients with DF on days 5-8 after onset of fever when sera were available (data not presented). Sera of patients with DHF contained higher levels of sIL-2R, sCD4, and sCD8 than the sera of patients with DF. These results indicate that the levels of activation of CD4' and CD8' T lymphocytes are higher in DHF than in DF, and suggest that high levels ofT cell activation may be associated with the pathogenesis of DHF. However, the possibility that the higher levels ofsoluble factors in DHF reflect a high level of inflammatory responsiveness rather than actually causing hemorrhage and plasma leakage cannot be ruled out.
Elevated levels of sIL-2R have been reported in measles (26) , HTLV-1 (27) , and HIV infections (28) (29) (30) . Elevated levels of sCD8 have been reported in measles (26) and EpsteinBarr virus infections (23) . Elevated levels of IFNy have been reported in measles (31) . We also observed elevated levels of sIL-2R, IL-2, and IFNy in the sera of Thai children with uncharacterized febrile diseases other than DF, DHF, and Japanese encephalitis (data not presented). These results suggest that T lymphocytes are activated during systemic virus infections, and that elevation of serum levels of sIL-2R, sCD4, sCD8, IL-2, and IFN-y is not unique to dengue virus infections.
The role of lymphokines in the pathogenesis of DHF is an interesting subject to be studied. IL-2 induces plasma leakage in humans when administered at doses > lOs U/kg (32, 33) . Although the mechanism of the IL-2-induced plasma leakage is not clearly understood, IL-2 is known to induce lymphokineactivated killer (LAK) cells (34) and thromboxane A2 (35) , and activate endothelial cells (36) , any of which may conceivably alter endothelial permeability to cause plasma leakage. Activation ofthe complement system, which is observed in DHF (1), has been observed in patients administered high doses of IL-2, and the levels of plasma C3a correlated with signs of vascular leak syndrome (37) . These observations suggest that the high levels of IL-2 detected in the sera ofpatients with DHF may be one factor which contribute to plasma leakage and shock in DSS. However, we detected similar levels of IL-2 in the sera of patients with DF, therefore, it is unlikely that IL-2 alone induces DHF.
We have hypothesized that IFN-y produced by dengue specific T cells may contribute to the pathogenesis of DHF (14) . It is known that IFNy increases the number of FcyRI on monocytic cells (38, 39) . We have reported that IFNy augments dengue virus infection ofhuman monocytic cells in the presence of antibody to dengue viruses (1 1). IFNy also up-regulates expression of HLA class I and class II antigens (40) . These effects of IFNy may increase the number ofdengue virus-infected monocytes and facilitate recognition ofdengue virus antigen by dengue virus-specific T cells. The lysis of dengue virus-infected monocytes by these CTL may release vasoactive mediators which contribute to DHF. The elevated levels of IFNy in the sera of most of the dengue patients suggest that these mechanisms may occur in vivo. However, we detected similar levels ofIFNy in DHF and DF; therefore, IFNy alone is probably not responsible for the pathogenesis of DHF. It is possible that cytokines released from monocytes may contribute to the pathogenesis ofDHF. We did not detect TNFa in the sera of 18 patients with DHF between days 1 and 11 (data not presented). However, it is interesting to examine serum levels of other monokines in patients with DHF or DF.
We observed significant correlations between the severity of illness (DHF vs. DF) and elevated levels of sIL-2R, sCD4, and sCD8, but not with elevated levels oflymphokines. Plasma T Cell Activation in Dengue 1479 leakage during dengue virus infections may not be the result of any single lymphokine. Marked activation ofT cells does however appear to be a feature of such cases. Therefore, future examination of the interaction of immune effector cells and infected target cells will be important to elucidate the pathogenesis of plasma leakage. Despite our failure to detect a correlation between serum levels oflymphokines and plasma leakage, we want to emphasize that the patients we investigated were admitted to the hospital when symptoms were already severe or rapidly worsening. It is possible that many of the host immune responses had been already activated and some of the secreted lymphokines had been eliminated or degraded before sera were obtained. It would be desirable to serially evaluate a cohort of patients beginning earlier in the course of dengue virus infection to determine whether elevated serum levels of specific lymphokines predict the appearance ofplasma leakage.
